4Korst RJ,Crystal RG.Active,specific immunotherapy for lung cancer: hurdles and strategies using genetic modification.Ann Thorac Surg,2003,76(4):1319-1326.
5Nair SK,Morse M,Boczkowski D,et al.Induction of tumor-specific cytotoxic T lymphocytes in cancer patients by autologous tumor RNA-transfected dendritic cells.Ann Surg,2002,235(4):540-549.
6Zhou Y,McEarchern JA.Dendritic cells efficiently acquire and present antigen derived from lung cancer cells and induce antigen-specific T-cell responses.Cancer Immunol Immunother,2003,52(7):413-422.
7Nemunaitis J,Sterman D.Granulocyte-macrophage colony-stimulating factor gene-modified autologous tumor vaccines in non-small-cell lung cancer.J Natl Cancer Inst,2004,96(4):326-331.
8Hege KM,Carbone DP.Lung cancer vaccines and gene therapy.Lung Cancer Volume,2003,41(1):103-113.
9Spira A,Ettinger DS.Multidisciplinary management of lung cancer.N Engl J Med,2004,350(4):379-392.
10Spiro SG,Porter JC.Lung cancer-where are we today? Current advances in staging and nonsurgical treatment.Am J Respir Crit Care Med,2002166(9):1166-1196.
同被引文献13
1Waller DA.Surgery for non-small cell lung cancer new trends[J].Lung Cancex,2001,34(Suppl 2):S133-136.
2Sheplerd FA,Dancey J,Ramlau R,et al.Prospective randomized trial of docetaxel versus best supportive care in patients with non-small cell lung cancer previovly treated with pl atimum-based chemotherapy[J].J Clin Oncol,2000,18(10):2095-2103.
3Van Zandwijk N,Smit EF,Kramer GW,et al.Gemcitabine and cisplatin as induction regimen for patients with biopsy-proven stage Ⅲ A N2 non-small cell lung cancer:a phase Ⅱ study of the Europan organization for research and treatment of cancer[J].J Clin Oncol,2000,18(14):2658-2664.
4Voltolini I,Luzzi L,G hiribelli C,et al.Results of induction chemotherapy followed by surgical resection in patients with stage Ⅲ A(N2) nonsmall cell lung cancer:the importance of the nodal downstaging after chemotherapy[J].Eur J Cardiothorac Surg,2001,20(9):1106-1112.
5Yang CH,Tsai CM.Gemcitabine and cisplatin in a multimodality treatment for local advanced non-small cell lung cancer[J].Br J Cancer,2002,86(2):190-195.
6Van Kooten M,Rosenberg M.Phase Ⅱ study of Gemcitabine(Gem)plus cisplatin (Cis) as induction chemotherapy regimen for patients(pts) with stageⅢ A-Ⅲ B non-small cell lung cancer(NSCLC):preliminary report[J].Proc Am Soc Clin Oncol,1999,18(5):526.
7Crino L,Betti M.Induction chemotherapy with Gemcitabine and cisplatin in locally advanced stageⅢ non-small cell lung cancer.A phase Ⅱ study[J].Proc Am Soc Clin Oncol,1999,18(5):488.
8Migiorino MR,DE Marinis.Gemcitabine and cisplatin as induction chemotherapy in stageⅢ AN2/ⅢB non-small cell lung cancer(NSCLC).A mono-in-situtional phase Ⅱ study with a 21 days schedule[J].Proc Am Soc Clin Oncol,2000,19(6):530.
